1. OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up. (15th June 2017) Authors: Volkmann, ER; Sim, M; Tashkin, DP; Khanna, D; Clements, PJ; Roth, M; Furst, D; Pickney, A; Goldmuntz, E; Keyes-Elstein, L; Elashoff, R; Sullivan, K Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗